Cargando…
Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b
BACKGROUND: Glycogen storage disease type 1b (GSD1b) is an autosomal recessive lysosomal storage disease caused by defective glucose-6-phosphate transporter encoded by SLC37A4 leading to the accumulation of glycogen in various tissues. The high rate of consanguineous marriages in Tunisian population...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142411/ https://www.ncbi.nlm.nih.gov/pubmed/37118808 http://dx.doi.org/10.1186/s13098-023-01065-2 |
_version_ | 1785033606841761792 |
---|---|
author | Chkioua, Latifa Amri, Yessine Sahli, Chayma Rhouma, Ferdawes Ben Chehida, Amel Ben Tebib, Neji Messaoud, Taieb Abdennebi, Hassen Ben Laradi, Sandrine |
author_facet | Chkioua, Latifa Amri, Yessine Sahli, Chayma Rhouma, Ferdawes Ben Chehida, Amel Ben Tebib, Neji Messaoud, Taieb Abdennebi, Hassen Ben Laradi, Sandrine |
author_sort | Chkioua, Latifa |
collection | PubMed |
description | BACKGROUND: Glycogen storage disease type 1b (GSD1b) is an autosomal recessive lysosomal storage disease caused by defective glucose-6-phosphate transporter encoded by SLC37A4 leading to the accumulation of glycogen in various tissues. The high rate of consanguineous marriages in Tunisian population provides an ideal environment to facilitate the identification of homozygous pathogenic mutations. We aimed to determine the clinical and genetic profiles of patients with GSD1b to evaluate SLC37A4 mutations spectrum in Tunisian patients. METHODS: All exons and flanking intron regions of SLC37A4 gene were screened by direct sequencing to identify mutations and polymorphisms in three unrelated families with GSD1b. Bioinformatics tools were then used to predict the impacts of identified mutations on the structure and function of protein in order to propose a function-structure relationship of the G6PT1 protein. RESULTS: Three patients (MT, MB and SI) in Families I, II and III who had the severe phenotype were homoallelic for the two identified mutations: p.R300H (famillies I, II) and p.W393X (Family III), respectively. One of the alterations was a missense mutation p.R300H of exon 6 in SLC37A4 gene. The analysis of the protein structure flexibility upon p.R300H mutation using DynaMut tool and CABS-flex 2.0 server showed that the reported mutation increase the molecule flexibility of in the cytosol region and would probably lead to significant conformational changes. CONCLUSION: This is the first Tunisian report of SLC37A4 mutations identified in Tunisia causing the glycogenosis type Ib disease. Bioinformatics analysis allowed us to establish an approximate structure-function relationship for the G6PT1 protein, thereby providing better genotype/phenotype correlation knowledge. |
format | Online Article Text |
id | pubmed-10142411 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101424112023-04-29 Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b Chkioua, Latifa Amri, Yessine Sahli, Chayma Rhouma, Ferdawes Ben Chehida, Amel Ben Tebib, Neji Messaoud, Taieb Abdennebi, Hassen Ben Laradi, Sandrine Diabetol Metab Syndr Research BACKGROUND: Glycogen storage disease type 1b (GSD1b) is an autosomal recessive lysosomal storage disease caused by defective glucose-6-phosphate transporter encoded by SLC37A4 leading to the accumulation of glycogen in various tissues. The high rate of consanguineous marriages in Tunisian population provides an ideal environment to facilitate the identification of homozygous pathogenic mutations. We aimed to determine the clinical and genetic profiles of patients with GSD1b to evaluate SLC37A4 mutations spectrum in Tunisian patients. METHODS: All exons and flanking intron regions of SLC37A4 gene were screened by direct sequencing to identify mutations and polymorphisms in three unrelated families with GSD1b. Bioinformatics tools were then used to predict the impacts of identified mutations on the structure and function of protein in order to propose a function-structure relationship of the G6PT1 protein. RESULTS: Three patients (MT, MB and SI) in Families I, II and III who had the severe phenotype were homoallelic for the two identified mutations: p.R300H (famillies I, II) and p.W393X (Family III), respectively. One of the alterations was a missense mutation p.R300H of exon 6 in SLC37A4 gene. The analysis of the protein structure flexibility upon p.R300H mutation using DynaMut tool and CABS-flex 2.0 server showed that the reported mutation increase the molecule flexibility of in the cytosol region and would probably lead to significant conformational changes. CONCLUSION: This is the first Tunisian report of SLC37A4 mutations identified in Tunisia causing the glycogenosis type Ib disease. Bioinformatics analysis allowed us to establish an approximate structure-function relationship for the G6PT1 protein, thereby providing better genotype/phenotype correlation knowledge. BioMed Central 2023-04-28 /pmc/articles/PMC10142411/ /pubmed/37118808 http://dx.doi.org/10.1186/s13098-023-01065-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Chkioua, Latifa Amri, Yessine Sahli, Chayma Rhouma, Ferdawes Ben Chehida, Amel Ben Tebib, Neji Messaoud, Taieb Abdennebi, Hassen Ben Laradi, Sandrine Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b |
title | Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b |
title_full | Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b |
title_fullStr | Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b |
title_full_unstemmed | Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b |
title_short | Identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b |
title_sort | identification of mutations that causes glucose-6-phosphate transporter defect in tunisian patients with glycogenosis type 1b |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142411/ https://www.ncbi.nlm.nih.gov/pubmed/37118808 http://dx.doi.org/10.1186/s13098-023-01065-2 |
work_keys_str_mv | AT chkioualatifa identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b AT amriyessine identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b AT sahlichayma identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b AT rhoumaferdawesben identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b AT chehidaamelben identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b AT tebibneji identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b AT messaoudtaieb identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b AT abdennebihassenben identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b AT laradisandrine identificationofmutationsthatcausesglucose6phosphatetransporterdefectintunisianpatientswithglycogenosistype1b |